Nikhil is an Associate at F-Prime Capital and works across the healthcare sub-sectors including therapeutics, medical technology, and healthcare IT & services. Prior to joining F-Prime, Nikhil was an Associate at Audax Group in Boston, where he focused on private equity investments in healthcare.
Nikhil received a B.A. in Biology from the University of Pennsylvania and a B.S. in Economics from the Wharton School.
Eywa is a global generic pharmaceutical company engaged in research and development, manufacture, marketing, sale, and distribution of generic finished dosage formulations. Learn more at www.eywapharma.com.
Ivenix is dedicated to eliminating infusion-related patient harm, uniquely positioned at the crossroads of healthcare IT and infusion delivery. Learn more at www.ivenix.com.
Rallybio is a biopharmaceutical company focused on identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Learn more at www.rallybio.com.